Abraham J.P. Teunissen, PhD

BioMedical Engineering and Imaging Institute
NEW YORK, New York, United States

Disclosure information not submitted.

Presentation(s):

• SAT-716 - Preclinical Efficacy and Safety of A Therapeutic FSH-Blocking Antibody in Obesity and Alzheimer'S Disease Models

  Saturday, June 13, 2026
  9:30 AM - 4:30 PM CT